General Stage 1 findings support continued pivotal phase evaluation of gotistobartBy Healthcare Propulsion StaffSeptember 15, 20260 Patients with metastatic squamous non-small cell lung cancer (NSCLC) whose disease progressed following PD-(L)1 inhibitor therapy experienced a median overall…
